Lymph node ratio determines the benefit of adjuvant radiotherapy in pathologically 3 or less lymph node-positive prostate cancer after radical prostatectomy: a population-based analysis with propensity-score matching-Reference-Cited by-同舟云学术

Lymph node ratio determines the benefit of adjuvant radiotherapy in pathologically 3 or less lymph node-positive prostate cancer after radical prostatectomy: a population-based analysis with propensity-score matching

Published:2017-11-22 Issue:66 Volume:8 Page:110625-110634
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kim Yi-Jun¹,Song Changhoon¹,Eom Keun-Yong¹,Kim In Ah¹,Kim Jae-Sung¹

Affiliation:

1. Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer;Prostate International;2024-03

2. Semiautomated pelvic lymph node treatment response evaluation for patients with advanced prostate cancer: based on MET-RADS-P guidelines;Cancer Imaging;2023-01-17

3. What is the best time for postoperative radiation therapy in pN1 prostate cancer?;Neoplasma;2023

4. The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non–small Cell Lung Cancer;Clinical Lung Cancer;2022-09

5. Nomograms for Metastasis-Free and Overall Survival for Pathologically Node Positive Prostate Cancer Patients Treated With or Without Radiation Therapy Plus Short-Term ADT;Clinical Genitourinary Cancer;2022-06